Abstract
BackgroundImmune checkpoint inhibitors (ICIs) are becoming the standard of care for recurrent and metastatic cancer. Opioids, the primary treatment for cancer-related pain, are immunosuppressive raising concerns about their potential to...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have